EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Applied DNA Sciences's enterprise value is $2.71 Mil.
Applied DNA Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.20 Mil. Therefore, Applied DNA Sciences's EV-to-EBITDA for today is -0.22.
The historical rank and industry rank for Applied DNA Sciences's EV-to-EBITDA or its related term are showing as below:
APDN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.52 Med: -3.15 Max: 0.19
Current: -0.22
During the past 13 years, the highest EV-to-EBITDA of Applied DNA Sciences was 0.19. The lowest was -23.52. And the median was -3.15.
APDN's EV-to-EBITDA is ranked worse than 100% of 118
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.53
vs APDN: -0.22
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Applied DNA Sciences's stock price is $4.776.
Applied DNA Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-11.000. Therefore, Applied DNA Sciences's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Applied DNA Sciences EV-to-EBITDA Historical Data
The historical data trend for Applied DNA Sciences's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Applied DNA Sciences's EV-to-EBITDA
For the Diagnostics & Research subindustry, Applied DNA Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied DNA Sciences's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Applied DNA Sciences's EV-to-EBITDA falls into.
Applied DNA Sciences EV-to-EBITDA Calculation
Applied DNA Sciences's EV-to-EBITDA for today is calculated as:
Applied DNA Sciences's current Enterprise Value is $2.71 Mil.
Applied DNA Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied DNA Sciences (NAS:APDN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Applied DNA Sciences's PE Ratio for today is calculated as:
Applied DNA Sciences's share price for today is $4.776.
Applied DNA Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Applied DNA Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Applied DNA Sciences (Applied DNA Sciences) Business Description
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APDN has been successfully added to your 